tiprankstipranks
Advertisement
Advertisement
Analyst Reiterates Hold on Lantheus as Strong Q1 Fails to Shift Cautious Long‑Term Outlook and PSMA-PET Uncertainty
PremiumRatingsAnalyst Reiterates Hold on Lantheus as Strong Q1 Fails to Shift Cautious Long‑Term Outlook and PSMA-PET Uncertainty
27d ago
Lantheus price target raised to $100 from $95 at Mizuho
Premium
The Fly
Lantheus price target raised to $100 from $95 at Mizuho
27d ago
Lantheus price target raised to $115 from $85 at Citizens
Premium
The Fly
Lantheus price target raised to $115 from $85 at Citizens
27d ago
AI Models Stay Constructive on Lantheus as a Transitional Period Approaches
PremiumAI Analyst RatingsAI Models Stay Constructive on Lantheus as a Transitional Period Approaches
1M ago
Lantheus Shareholders Approve Governance Changes and Incentive Plan
Premium
Company Announcements
Lantheus Shareholders Approve Governance Changes and Incentive Plan
1M ago
Lantheus price target raised to $97 from $84 at B. Riley
Premium
The Fly
Lantheus price target raised to $97 from $84 at B. Riley
1M ago
Lantheus announces FDA approval of Pylarify TruVu injection
PremiumThe FlyLantheus announces FDA approval of Pylarify TruVu injection
3M ago
Lantheus receives U.S. FDA tentative approval for Lutetium Lu 177
Premium
The Fly
Lantheus receives U.S. FDA tentative approval for Lutetium Lu 177
3M ago
Lantheus price target raised to $89 from $82 at Truist
Premium
The Fly
Lantheus price target raised to $89 from $82 at Truist
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100